COMPA is the Coalition of Medication-Assisted Treatment Providers and Advocates of New York State. We are a non-profit membership organization dedicated to treating addiction through the use of pharmacotherapy as a part of a comprehensive bio-psycho-social approach to treatment.
Our member programs treat more than 41,000 New Yorkers from every corner of our state and help them to overcome their dependence on illicit opioids and other drugs. COMPA, along with our member treatment programs, affiliate members, and corporate members works to improve all aspects of the lives of our patients. This involves advocacy with federal, state, and local governments as well as a variety of educational activities.
We actively encourage the adoption of the latest evidence-based practice in order to improve our quality of care and in order to obtain the best possible treatment outcomes. Further we seek the resources and regulatory flexibility to expand treatment availability and to improve treatment quality throughout New York State.
COMPA’s program members provide Medication Assisted Treatment and include both Opioid Treatment Programs (OTPs) and Office-Based Opioid Treatment (OBOT) providers
The OTPs are essential treatment providers with a specialized mission to treat individuals with opioid dependence. There is approximately one-third of the OASAS system receiving treatment in OTPs. OTP services are crucial to New York’s healthcare system, and are critical during the current prescription opioid and heroin epidemic. OTPs are the only treatment modality where all three federally approved medications are available, methadone, buprenorphine and extended-release injectable naltrexone (Vivitrol). OTPs provide basic medical assessments that include physical exam and bloodwork, as well as comprehensive, multi-disciplinary treatment which includes counseling and medications. In addition to NYS licensing regulations, OTPs must meet rigorous federal accreditation standards.
OTPs and OBOTs collaborate in a variety of treatment models. OTPs are able to provide support and resources to OBOT providers, enabling DATA-waived qualifying physicians and mid-level practitioners across New York to treat a greater number of patients and respond to the epidemic more effectively. Patients who are not able to stabilize in OBOT can be transferred to OTPs. Conversely, stabilized OTP patients may be managed and monitored in an OBOT.
Compa is the New York State member program of the American Association for the Treatment of Opioid Dependence (AATOD). We are proud to represent New York State’s Opioid Treatment Programs in AATOD.